Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function

Journal of Immunotherapy

Volumn 20, Issue 2, 1997, Pages 101-110

  De Kroon, Judith F E M ^a   Van Bergen, Cornelis A M ^a   De Paus, Roelof A ^a   Kluin Nelemans, Hanneke C ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adoptive immunotherapy; Human cytotoxic T cell clones; Human lymphoma; SCID mice

Indexed keywords

CD8 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TARGET CELL; XENOTRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; CLONE CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOMA, B-CELL; MALE; MICE; MICE, SCID; RECOMBINANT PROTEINS; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031463907     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Weidmann E, Trucco M, Whiteside TL. Relevance of the T cell receptor for immunotherapy of cancer. Cancer Immunol Immunother 1994;39:1-14.
2. Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes. Science 1986;233:1318-21.
3. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. N Engl J Med 1988;319:1676-80.
4. Topalian SL, Solomon D, Avis FP, et al. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 1988;6:839-53.
5. Melief CJM. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 1992;58:143-75.
6. Melief CJM, Kast WM. Lessons from T cell responses to virus induced tumours for cancer eradication in general. Cancer Surv 1992;13:81-99.
7. Kast WM, Offringa R, Peters PJ, Voordouw AC, et al. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 1989;59:603-14.
8. Greenberg PD, Klarnet JP, Kern DE, Cheever MA. Therapy of disseminated tumours by adoptive transfer of specifically immune T cells. Prog Exp Tumour Res 1988;32:104-27.
9. Boon T. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int J Cancer 1993;54:177-80.
10. Brichard V, van Pel A, Wolfel T, et al. The tyrosinase gene codes for an antigen recognized by auto ogous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178:489-95.
11. Finke JH, Rayman P, Edinger M. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T-cell line. J Immunother 1992;11:1-11.
12. Freedman RS, Ionnides CG, Mathioudakis G, Platsoucas CD. Novel immunologic strategies in ovarian carcinoma. Am J Obstet Gynecol 1992;167:1470-8.
13. Faber LM, van Luxemburg-Heijs SAP, Willemze R, Falkenburg JHF. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992;176:1283-9.
14. Bosma GC, Custer RP, Bosma JM. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-30.
15. Mosier DE. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv Immunol 1991;50:303-25.
16. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-9.
17. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-9.
18. Marijt WAF, Veenhof WFJ, Brand A, et al. Minor histocompatibility antigen specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells. J Exp Med 1991;173:101-9.
19. Kluin-Nelemans HC, Limpkens J, Meeraboux J, et al. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t (14;18) (q32;q21). Leukemia 1991;5:221-4.
20. Voogt PJ, Fibbe WE, Marijt WAF, et al. Rejection of bone marrow graft by recipient-derived cytotoxic T lymphocytes directed against minor histocompatibility antigens. Lancet 1990;335:131-4.
21. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982;155:1823-41.
22. Goulmy E. HLA-A-B restriction of cytotoxic T cells. In: Ferrone S, Solheim BG, eds. HLA-typing: methodology and clinical aspects. New York: CRC Press, 1982:105.
23. Taylor JJ, Rowe D, Williamson IK, Christmas SE, Proctor SJ, Midleton PG. Detection of T-cell receptor γ chain V rearragements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia. Blood 1995;85:1989-95.
24. de Kroon JFEM, Kluin PM, Kluin-Nelemans HC, Willemze R, Falkenburg JHF. Homing and antigenic characterization of a human non-Hodgkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice. Leukemia 1994;8:1385-91.
25. Ridell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 1992;257:238-41.
26. Rooney CM, Smith CA, Ng CYC, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995;345:9-13.
27. Cheever MA, Britzmann Thompson D, Klarnet JP, Greenberg PD. Antigen-driven long-term cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells. J Exp Med 1986;163:1100-12.
28. Martino G, Anastasi J, Feng J, McShan C, DeGroot L, Quintans J, Grimaldi LME. The fate of human peripheral blood lymphocytes after transfer into SCID mice. Eur J Immunol 1993;23:1023-8.
29. Vormoor J, Lapidot T, Pflumoi F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83: 2489-97.
30. Amstrong N, Cigel F, Borcherding W, Hong R, Malkovska V. In vitro preactivated human T cells engraft in SCID mice and migrate to murine lymphoid tissues. Clin Exp Immunol 1992;90:476-82.
31. Abonour R, Cigel FK, Schell K, Barnstable CS, Sabatini LM, Malkovska V. Survival and tissue distribution of human T-cell clones in SCID mice. J Immunother 1995;18:10-18.
32. Hoffmann-Frezer G, Gall C, Zengerle U, Kranz B, Thierfelder S. Immunohistory and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993;81:3440-8.
33. Jicha DL, Yannelli JR, Custer M, et al. The persistence of human peripheral blood lymphocytes, tumor infiltrating lymphocytes, and colon adenocarcinomas in immunodefiecient mice. J Immunother 1992;11:19-29.
34. Ladel CH, Kaufmann SHE, Bamberger U. Localisation of human peripheral blood leukocytes after transfer to CB-17 scid/scid mice. Immunol Lett 1993;38:63-8.
35. Pfeffer K, Heeg K, Bubeck R, Conradt P, Wagner H. Adoptive transfer of human peripheral blood lymphocytes (PBL) in SCID mice. Curr Top Microbiol Immunol 1989;152:211-7.
36. Simpson E, Farrant J, Chandler P. Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in SCID mice. Immunol Rev 1991;124:97-111.
37. Krams SM, Dorschkind K, Gerschwin ME. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 1989; 170:1919-30.
38. Tary-Lehmann M, Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med 1992;175:503-16.